D. Montero

781 total citations
12 papers, 501 citations indexed

About

D. Montero is a scholar working on Psychiatry and Mental health, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, D. Montero has authored 12 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Surgery and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in D. Montero's work include Pathogenesis and Treatment of Hiccups (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). D. Montero is often cited by papers focused on Pathogenesis and Treatment of Hiccups (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). D. Montero collaborates with scholars based in Spain, France and Sweden. D. Montero's co-authors include Francisco J. de Abajo, Luis A. Garcı́a Rodrı́guez, Marı́a L. de Ceballos, José Antonio del Rı́o, Mariano Madurga, Olof Beck, Björn Mårtensson, Kerstin Brodin, A. Wägner and Marie Åsberg and has published in prestigious journals such as Life Sciences, British Journal of Dermatology and Acta Psychiatrica Scandinavica.

In The Last Decade

D. Montero

12 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Montero Spain 7 162 122 108 74 43 12 501
Julian Casciano United States 14 192 1.2× 102 0.8× 103 1.0× 69 0.9× 15 0.3× 32 566
Alin Andries Denmark 13 210 1.3× 70 0.6× 146 1.4× 156 2.1× 62 1.4× 23 726
Robert Edson United States 15 352 2.2× 152 1.2× 84 0.8× 192 2.6× 87 2.0× 26 1.0k
Mark E. Lehman United States 5 123 0.8× 180 1.5× 90 0.8× 42 0.6× 19 0.4× 7 577
Mingyuan Zhang China 11 70 0.4× 81 0.7× 74 0.7× 34 0.5× 19 0.4× 35 412
T. Hansen Norway 13 72 0.4× 122 1.0× 80 0.7× 42 0.6× 17 0.4× 32 599
Welmoed E. E. Meijer Netherlands 4 118 0.7× 110 0.9× 93 0.9× 26 0.4× 24 0.6× 6 315
Sandarsh Surya United States 6 114 0.7× 107 0.9× 63 0.6× 44 0.6× 23 0.5× 10 302
Javier García del Pozo Spain 12 41 0.3× 65 0.5× 75 0.7× 47 0.6× 100 2.3× 33 455
S. Sjövall Finland 15 72 0.4× 66 0.5× 33 0.3× 245 3.3× 49 1.1× 23 512

Countries citing papers authored by D. Montero

Since Specialization
Citations

This map shows the geographic impact of D. Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Montero more than expected).

Fields of papers citing papers by D. Montero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Montero. The network helps show where D. Montero may publish in the future.

Co-authorship network of co-authors of D. Montero

This figure shows the co-authorship network connecting the top 25 collaborators of D. Montero. A scholar is included among the top collaborators of D. Montero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Montero. D. Montero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Abajo, Francisco J. de, et al.. (2000). Antidepressant drugs: a potential new drug cause of upper gastrointestinal bleeding. Digestive and Liver Disease. 32(6). 455–457. 8 indexed citations
3.
Abajo, Francisco J. de, Luis A. Garcı́a Rodrı́guez, & D. Montero. (1999). Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ. 319(7217). 1106–1109. 313 indexed citations
4.
Prieto, M., et al.. (1998). [Use of antihypertensive drugs in Spain, 1985-1995].. PubMed. 110(7). 247–53. 28 indexed citations
5.
Alonso, Pino, et al.. (1997). [Evolution of antidepressive drug consumption in Spain. The impact of selective serotonin re-uptake inhibitors].. PubMed. 108(5). 161–6. 24 indexed citations
6.
Moore, Nicholas, et al.. (1994). Communication in pharmacovigilance. Pharmacoepidemiology and Drug Safety. 3(3). 151–155. 4 indexed citations
7.
Montero, D., et al.. (1994). Electronic transmission of rapid alerts in pharmacovigilance: A pilot EC experiment. Pharmacoepidemiology and Drug Safety. 3(3). 163–167. 4 indexed citations
8.
Moore, Nicholas, et al.. (1994). The single case format: Proposal for a structured message for the telematic transmission of information on individual case reports in pharmacovigilance. Pharmacoepidemiology and Drug Safety. 3(3). 157–162. 5 indexed citations
9.
Abajo, Francisco J. de, et al.. (1993). Trends in the supply and use of lipid-lowering drugs in Spain, 1983 through 1991.. PubMed. 48(2). 145–9. 5 indexed citations
10.
Romero, Gonzalo, et al.. (1992). Effect of prenatal exposure to tianeptine on different neurotransmitter receptors and 5-HT-stimulated inositol phosphate formation in rat brain. Journal of Neural Transmission. 90(2). 113–124. 4 indexed citations
11.
Mårtensson, Björn, A. Wägner, Olof Beck, et al.. (1991). Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3 H‐imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatrica Scandinavica. 83(2). 125–133. 40 indexed citations
12.
Montero, D., Marı́a L. de Ceballos, & José Antonio del Rı́o. (1990). Down-regulation of 3H-imipramine binding sites in rat cerebral cortex after prenatal exposure to antidepressants. Life Sciences. 46(22). 1597–1600. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026